Xuzhao Zhang

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Teclistamab-Induced Localized Pleural Cavity Cytokine Release Syndrome in a Multiple Myeloma Patient Managed with Intrapleural Dexamethasone Administration.

Teclistamab-Induced Localized Pleural Cavity Cytokine Release Syndrome in a Multiple Myeloma Patient Managed with Intrapleural Dexamethasone Administration.

Journal: Journal of blood medicine

Published: December 12, 2025

Targeting CaMKIIδ overcomes therapy resistance in acute myeloid leukemia by suppressing the STAT3/CDK6/BCL-2 survival axis.

Targeting CaMKIIδ overcomes therapy resistance in acute myeloid leukemia by suppressing the STAT3/CDK6/BCL-2 survival axis.

Journal: Journal of leukocyte biology

Published: May 15, 2025

HERV-K TM Subunit Elicits CD8+ T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC.

HERV-K TM Subunit Elicits CD8+ T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 23, 2024

CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial.

CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial.

Journal: Cancer immunology research

Published: January 14, 2024

An oral triple pill-based cocktail effectively controls acute myeloid leukemia with high translation.

An oral triple pill-based cocktail effectively controls acute myeloid leukemia with high translation.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 06, 2023

UBE2L3 Reduces TRIM21 Expression and IL-1β Secretion in Epidermal Keratinocytes and Improves Psoriasis-Like Skin.

UBE2L3 Reduces TRIM21 Expression and IL-1β Secretion in Epidermal Keratinocytes and Improves Psoriasis-Like Skin.

Journal: The Journal of investigative dermatology

Published: June 08, 2022

Primary hepatopancreatobiliary lymphoma: Pathogenesis, diagnosis, and management.

Primary hepatopancreatobiliary lymphoma: Pathogenesis, diagnosis, and management.

Journal: Frontiers in oncology

Published: May 23, 2022

Aberrantly Activated APOBEC3B Is Associated With Mutant p53-Driven Refractory/Relapsed Diffuse Large B-Cell Lymphoma.

Aberrantly Activated APOBEC3B Is Associated With Mutant p53-Driven Refractory/Relapsed Diffuse Large B-Cell Lymphoma.

Journal: Frontiers in immunology

Published: March 02, 2022

A Selective Small-Molecule c-Myc Degrader Potently Regresses Lethal c-Myc Overexpressing Tumors.

A Selective Small-Molecule c-Myc Degrader Potently Regresses Lethal c-Myc Overexpressing Tumors.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 29, 2021

Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.

Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.

Journal: Frontiers in oncology

Published: April 11, 2021

Myeloid sarcoma of the pancreas: A case report and literature review.

Myeloid sarcoma of the pancreas: A case report and literature review.

Journal: Medicine

Published: November 27, 2020

Clearance of HBsAg in a patient with familial multiple myeloma after a bortezomib-based regimen combined with anti-HBV drug: A case report.

Clearance of HBsAg in a patient with familial multiple myeloma after a bortezomib-based regimen combined with anti-HBV drug: A case report.

Journal: Medicine

Published: October 06, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026